Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, discusses the importance of oncology practices participating in alternative payment models (APMs).
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, discusses the importance of oncology practices participating in alternative payment models (APMs).
Transcript:
What were some of the highlights from your panel on payment models?
So, I was fortunate enough to moderate a panel today on alternative payment models (APMs). We had a representative from Moffitt Cancer Center, a representative from the Memorial Healthcare System, and a representative from Florida Cancer [Specialists]. So that’s great because those are 3 very different practice settings all of whom are knee deep in APMs.
Two of the 3 are involved in the Oncology Care Model (OCM). Moffitt is not in the OCM because they’re a [prospective payment system] PPS-exempt hospital and were not allowed to participate.
But I think the take home messages were that overall the OCM has been a positive experience for the 2 groups that participated. They’ve learned a lot about how to optimize care delivery, they’ve looked at where they could improve care, they looked at the opportunities to improve the patient experience, and at the same time [were] cognizant of cost.
So, I would say one of the important takeaways was that for practices who were in the OCM, they would do it again, and that’s important. The second thing was that all 3 groups are participating in other APMs, and that is really good news. I think when the OCM was launched it was somewhat disappointing that so few commercial payers chose to participate. I was at Aetna at the time and we did choose to participate, but very few commercial payers did choose to participate.
Nonetheless, all three groups that we had on our panel today are participating in APMs, and that’s good news because I believe that the knowledge gained, for example, in the OCM is transferable to these other models, and our panelists said as much.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA Session Highlights the General Urologist’s Role in Gender-Affirming Care
May 7th 2024During her session, Polina Reyblat, MD, Kaiser Permanente Los Angeles Medical Center, highlighted best practices urologists should incorporate to make transgender and gender-diverse patients comfortable during physical exams and avoid retraumatization.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Detail Effects—and Uncertainty—of Drug Pricing Negotiations
May 7th 2024Research into the Inflation Reduction Act evaluated payer concerns, patient and physician behavior, which patients will benefit from the first 10 drugs selected for price negotiation, and the ripple effect into Medicaid at the state level.
Read More